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Abstract
Background: Hydrogen sulphide is a gas signalling molecule which is produced endogenously from
L-cysteine via the enzymes cystathionine beta-synthase (CBS) and cystathionine gamma-lyase
(CSE). The possible role of hydrogen sulphide in reproduction has not yet been fully investigated.
It has been previously demonstrated that hydrogen sulphide relaxes uterine smooth muscle in
vitro. The aim of the present study was to investigate the endogenous production of hydrogen
sulphide in rat and human intrauterine tissues in vitro.
Methods:  The production of hydrogen sulphide in rat and human intrauterine tissues was
measured in vitro using a standard technique. The expression of CBS and CSE was also investigated
in rat and human intrauterine tissues via Western blotting. Furthermore, the effects of nitric oxide
(NO) and low oxygen conditions on the production rates of hydrogen sulphide were investigated.
Results: The order of hydrogen sulphide production rates (mean +/- SD, n = 4) for rat tissues
were: liver (777 +/- 163 nM/min/g) > uterus (168 +/- 100 nM/min/g) > fetal membranes (22.3 +/-
15.0 nM/min/g) > placenta (11.1 +/- 4.7 nM/min/g), compared to human placenta (200 +/- 102 nM/
min/g). NO significantly increased hydrogen sulphide production in rat fetal membranes (P < 0.05).
Under low oxygen conditions the production of hydrogen sulphide was significantly elevated in
human placenta, rat liver, uterus and fetal membranes (P < 0.05). Western blotting (n = 4) detected
the expression of CBS and CSE in all rat intrauterine tissues, and in human placenta, myometrium,
amnion and chorion.
Conclusion: Rat and human intrauterine tissues produce hydrogen sulphide in vitro possibly via
CBS and CSE enzymes. NO increased the production of hydrogen sulphide in rat fetal membranes.
The augmentation of hydrogen sulphide production in human intrauterine tissues in a low oxygen
environment could have a role in pathophysiology of pregnancy.
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Background
The pharmacological, physiological and pathological
roles of gasotransmitters nitric oxide (NO) and carbon
monoxide (CO) have been extensively researched in the
reproductive system. NO donors have been demonstrated
to relax the myometrium [1] and maintain uterine quies-
cence [2]. CO has been demonstrated to relax smooth
muscle, including human myometrium via a sGC-cGMP
mechanism [3]. Hydrogen sulphide (H2S) is another
gasotransmitter that has many parallels with NO and CO
[4], however there are no reports to date on the produc-
tion of H2S in reproductive tissues. H2S is endogenously
produced from L-cysteine by two pyridoxal 5' phosphate-
dependent enzymes cystathionine β-synthase (CBS) and
cystathionine γ-lyase (CSE) [5-7]. A high expression of
CBS has been found in the central nervous system [8]
while CSE is highly expressed in vascular tissues in the rat
[9]. An early study by Smythe [10] observed the produc-
tion of H2S in rat liver from L-cysteine. In more recent
studies various mammalian tissues have been shown to
produce H2S, including the brain (50–160 μM), the
ileum, the kidneys and vascular tissue [8,11,12].
The physiological roles of H2S have been well established.
Abe and Kimura [8] suggested possible role of H2S as an
endogenous neuromodulator in rat brain tissue, where it
is involved in synaptic transmission. In the cardiovascular
system H2S acts as a vasodilator both in vivo and in vitro
and reduces blood pressure in vivo. The mechanism of
action of H2S is unknown. However, unlike NO, H2S
dilates blood vessels possibly via a novel mechanism that
involves the opening of K+ 
ATP channels [13]. The role of
H2S as an inflammatory mediator is supported by the
pharmacological inhibition of H2S biosynthesis by the
CSE enzyme inhibitor D,L-propargylglycine or β-cyano-L-
alanine in conditions such as acute pancreatitis, haemor-
rhagic shock and endotoxemia [14-16]. H2S as a smooth
muscle relaxant has been investigated in various smooth
muscle tissues. The H2S donor sodium hydrosulphide
(NaHS) relaxed guinea pig and rat ileum smooth muscle
and also the thoracic aorta and portal vein [11,17]. Sidhu
et al. [18] showed that NaHS relaxed isolated pregnant rat
uterine strips in vitro, demonstrating the role of H2S as a
smooth muscle relaxant. However the study did not inves-
tigate the production of H2S or the expression of the CBS
and CSE enzymes in intrauterine tissues, and this has not
been reported previously.
The aim of the present study was to investigate the endog-
enous production of H2S and identify the expression of
CBS and CSE enzymes in rat and human intrauterine tis-
sues.
Methods
Tissue collection
Tissue was collected from 36 pregnant Sprague-Dawley
rats (175–250 g) at 19 days of gestation and from 4 non-
pregnant Sprague-Dawley rats in the proestrous stage of
the oestrous cycle, in accordance with the Home Office
Guidance on the Operation of Animals (Scientific Proce-
dures) Act 1986. Rat tissue was collected at 19 days of ges-
tation as samples were required close to term, but not at
term, which corresponds to a time frame in human preg-
nancy when premature labour or pre-eclampsia could
occur. In pregnant rats, the uterus was incised and samples
of the amnion were dissected from the complete amniotic
sac, placentas were then removed from their attachment
sites and cleaned of any fetal membrane attachments.
Finally, whole samples of uterus were dissected out and
retained. In non-pregnant rats samples of the whole
uterus were dissected out. Samples of liver were retained
from each animal in order to provide positive controls. All
tissue samples were washed with sterile saline to remove
excess blood.
Human placentas with attached amnion and myometrial
samples were collected at four elective Caesarean sections
at term from normal pregnancies with informed consent
from the Women's Unit at University Hospital Coventry
and Warwickshire, with ethical approval from Coventry
Local Research Ethics Committee. Samples of amnion
were removed from the placentas and 2 cm core samples
of the placenta were obtained. Small samples of myo-
metrium were retained during the Caesarean section pro-
cedure. Unfortunately, samples from pre-eclamptic
placentas were not available in sufficient numbers for sta-
tistical comparison. All tissue samples were washed with
sterile saline to remove excess blood and were stored at -
80°C until use.
Endogenous production of H2S
The endogenous production of H2S was measured using
the methylene blue assay method of Zhao et al. [12] with
modifications. Ten grams of tissue were homogenised in
6–9 ml of ice-cold 50 mM potassium phosphate buffer
(pH 6.8). Fifty percent tissue homogenate was added to
ten 30 ml capacity universal containers loaded with a reac-
tion mixture of 100 mM potassium phosphate buffer (pH
7.4), 2 mM pyridoxal 5'phosphate and 10 mM L-cysteine.
Small plastic test tubes were used as centre wells contain-
ing 1% zinc acetate (0.5 ml) with a 5.5 cm filter paper to
trap evolved H2S. Septum lids were placed on the univer-
sal tubes which were then transferred to a shaking water
bath at 37°C and incubated for 6 hours. The reaction was
stopped after 6 hours by the injection of 50% trichloro-
acetic acid (0.5 ml) via the septum lid into the reaction
mixture. To ensure maximum trapping of evolved hydro-
gen sulphide the reaction was allowed to incubate for aReproductive Biology and Endocrinology 2009, 7:10 http://www.rbej.com/content/7/1/10
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further 1 hour in the shaking water bath. The methylene
blue assay was used to measure the sulphide concentra-
tion of the centre well contents. The contents of the centre
wells were transferred to test tubes and the following were
added to each tube: 3.5 ml of distilled water, 0.4 ml of
N,N-dimethyl-p-phenyldiamine sulphate (20 mM in 7.2
M HCl) and 0.4 ml of ferric chloride (30 mM in 1.2 HCl).
The tubes were incubated at room temperature for 20
minutes. The absorbance was measured at 670 nm on a
spectrophotometer (Cecil, Cambridge, UK). Calibration
standards were prepared using a 10 mM stock solution of
NaHS to produce a standard calibration curve. Sulphide
concentrations were measured and the production rate of
H2S was calculated. The experiment was run in parallel
without L-cysteine in the reaction mixture, as a negative
control. The effect of NO on H2S production was investi-
gated using the NO donor sodium nitroprusside (SNP)
(Sigma-Aldrich, Poole, UK). The reaction mixture was
incubated with 1 μM of SNP. The production of H2S
under low oxygen conditions was investigated by flushing
nitrogen gas into the universal tubes containing reaction
mixture before sealing with septum lids. The concentra-
tion of oxygen in the reaction tubes was not measured. All
experimental runs involved ten replicates.
Western blotting
The expression of CBS and CSE was investigated in rat and
human intrauterine tissues using Western blotting. Tissue
was lysed in lysis buffer and left to incubate on ice for 60
minutes. Supernatants were retained by centrifugation at
14,000 g for 20 minutes at 4°C. Supernatant samples (50
μg/μl) were prepared for Western blot with loading buffer.
Samples were separated on a 10% SDS-PAGE gel for 55
minutes at 150 V. The transfer of proteins was checked
with Ponceau stain (Sigma, Poole, UK). The SDS-PAGE
gel was transferred to PVDF membrane (Amersham, Buck-
inghamshire, UK) at 50 V for 2 hours. 5% non-fat dried
milk was used to block the membrane. The primary anti-
bodies for CSE and CBS were home made at Lakehead
University (Canada). The membrane was then incubated
with the primary antibody (dilution 1:500) overnight at
4°C. Primary antibody was removed by three 5 minute
washes with TBST. The membrane was incubated with sec-
ondary antibody (dilution 1:5000 for both goat anti-
mouse and goat anti-rabbit (Abcam, Cambridge, UK) for
1 hour at room temperature. Secondary antibody was
removed by three 5 minute washes with TBST. The ECL
Plus Western Blotting detection kit (Amersham, Little
Chalfont, UK) was used to detect the presence of the
enzymes using the ChemiDoc EQ imager (Bio-Rad,
Hemel Hempstead, UK). The PVDF membranes were rep-
robed with the loading control β-actin based on the
method used by Liao et al. [19] with some modifications.
After incubation with the ECL Plus Western Blotting
detection kit, the PVDF membranes were kept in fresh
TBST at 4°C for 24 hours. The PVDF membranes were
washed three times for 5 minutes with TBST. These mem-
branes were reprobed with β-actin antibody (Abcam,
Cambridge, UK) (dilution 1:1000) in 5% milk (non-fat
dried milk) overnight. The ECL Plus Western Blotting
detection kit was used to detect the presence of β-actin.
Rat kidney was used as a positive control for CBS, as it has
previously been detected in rat kidney [20]. For CSE the
positive control used was rat aorta. Non-pregnant (NP) rat
uterus was also investigated for the expression of both
CBS and CSE (n = 4).
The following rat tissues were investigated: uterus, pla-
centa and fetal membranes (amnion) (n = 4). Human tis-
sues investigated were: chorion, amnion, myometrium
and placenta (n = 4). The Western blotting technique used
was qualitative.
Statistical analysis
H2S production rates in nM min-1 g-1 wet tissue are shown
as mean ± SD. Mean production rates were compared
using Student's T test for unrelated samples or ANOVA
with a LSD posthoc test corrected for repeated tests, as
appropriate. P < 0.05 was considered statistically signifi-
cant.
Results
Assay validation
The coefficient of variation for the methylene blue assay
was 5.7%. The intrapair correlation was 0.975 (P < 0.001).
Basal production of H2S in rat liver, rat intrauterine tissues 
and human placenta
Rat intrauterine tissue and human placenta homogenates
produced H2S from L-cysteine in vitro (Table 1). Rat liver
homogenate (positive control) produced H2S at a much
higher rate than the rat intrauterine tissues (Table 1). The
order of H2S production rates was rat liver > human pla-
centa > rat uterus > rat fetal membranes > rat placenta
(Table 1).
Endogenous production of H2S in the presence of a nitric 
oxide donor
For rat liver there was a trend of increased production of
H2S in the presence of the NO donor, however the differ-
ence in mean production rates did not reach significance
(Table 2). A similar trend was observed for rat uterus and
rat placenta homogenates (Table 2). For rat fetal mem-
branes H2S production was significantly elevated in the
presence of the NO donor (p < 0.05) (Table 2).
Endogenous production of H2S under low oxygen 
conditions
Under low oxygen conditions production of H2S was sig-
nificantly increased compared to room air oxygen condi-Reproductive Biology and Endocrinology 2009, 7:10 http://www.rbej.com/content/7/1/10
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tions for rat liver, uterus and fetal membranes (P < 0.05),
but not rat placenta (Table 3). For human placenta there
was a significant increase in H2S production under low
oxygen conditions (P < 0.05) (Table 3).
Expression of CBS and CSE in rat intrauterine tissues
Figure 1 shows the expression of CBS in rat intrauterine
tissues. Expression of CBS was detected at 15 kDa in rat
tissues (Fig. 1a), while expression of CSE was detected at
43 kDa in all tissues investigated (Fig. 1b). β-actin was
used as a loading control for each Western blot and was
detected at 42 kDa.
Expression of CBS and CSE in human intrauterine tissues
Expression of CBS was detected at about 48 kDa in all
human tissue samples (Fig. 1c). The same human samples
were used to investigate the expression of CSE in intrauter-
ine tissues. CSE expression was detected at 43 kDa in all
human tissues (Fig. 1d). β-actin was used as loading con-
trols for these Western blots and expression was detected
at 42 kDa.
Discussion
Endogenous production of H2S in intrauterine tissues
The physiological role of H2S in the reproductive system
has not been fully investigated. Sidhu et al. [18] previously
showed that L-cysteine and NaHS relaxed pregnant rat
Table 1: Comparison of mean production rates of H2S from homogenates of rat liver, rat intrauterine tissues and human placenta (nM/
min/g) in the presence and absence (control) of 10 mM L-cysteine. 
Tissue Treatment H2S production rate (nM/min/g) Significance
Mean SD n
Rat liver Control 4.0 3.5 4
L-cysteine 777 163 4 P < 0.05
Rat uterus Control 0 0 4
L-cysteine 168 100 4 P < 0.05
Rat placenta Control 0 0 4
L-cysteine 11.1 4.7 4 P < 0.05
Rat fetal membranes Control 0 0 4
L-cysteine 22.3 15.0 4 P < 0.05
Human placenta Control 0 0 4
L-cysteine 200 102 4 P < 0.05
A value of 0 indicates below the level of detection.
Table 2: Effect of a nitric oxide donor on mean production rates of H2S from homogenates of rat liver and intrauterine tissues (nM/
min/g) in the presence and absence (negative control) of 10 mM L-cysteine.
Tissue Treatment H2S production rate (nM/min/g) Significance
Mean SD n
Rat liver -ve control 4.0 3.5 4
L-cysteine 575 172 4
+ NO donor 596 174 4 NS
Rat uterus -ve control 0 0 4
L-cysteine 438 277 4
+ NO donor 433 224 4 NS
Rat placenta -ve control 0 0 4
L-cysteine 45.7 51.6 4
+ NO donor 51.6 26.2 4 NS
Rat fetal membranes -ve control 0 0 4
L-cysteine 43.4 20.3 4
+ NO donor 57.4 31.5 4 P < 0.05
A value of 0 indicates below the level of detection.Reproductive Biology and Endocrinology 2009, 7:10 http://www.rbej.com/content/7/1/10
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uterus in vitro, however the endogenous production of
H2S in intrauterine tissue was not investigated in that
study. In the present study we are the first to report the
production of H2S in rat and human intrauterine tissues.
The baseline production of H2S in rat intrauterine tissues
was established in the present study. The results showed
that in the absence of additional L-cysteine all rat intrau-
terine tissues produced very low levels of H2S, the greatest
value was for rat liver (4.01 ± 3.5 min-1g wet tissue-1). The
tissue homogenates would have contained some blood
and a small concentration of endogenous L-cysteine
would have been present. It is also possible that when the
homogenates were acidified with trichloroacetic acid
some sulphide ions present were driven off as H2S.
With the addition of 10 mM L-cysteine a significant
increase in the production of H2S was observed in all tis-
sues. Rat liver produced H2S at a significantly higher pro-
duction rate in comparison to all intrauterine tissues; this
is possibly due to the high expression of CSE in rat liver
[6,7]. The present study showed that rat uterus produced
H2S at a greater rate than rat placenta and fetal mem-
branes; the lowest production rate was observed in rat pla-
centa. Human placenta exhibited significant H2S
production. The present study showed that H2S can be
produced from L-cysteine in intrauterine tissues.
The endogenous production of H2S in the presence of a 
nitric oxide donor
Earlier studies have demonstrated the effect of NO on the
production of H2S. Zhao et al. [12] demonstrated that NO
up-regulated the production of H2S. In the present study
comparison of treatments of L-cysteine and the NO donor
showed no significant difference in the production of H2S,
showing that the NO donor did not affect the production
of H2S. Similar results were observed with rat uterus and
placenta. In rat fetal membranes the presence of the NO
donor showed a significantly (P < 0.05) elevated produc-
tion rate in comparison to the L-cysteine treatment alone
(Table 2). A similar result was observed by Zhao et al. [12]
where the production of H2S was up-regulated by SNP in
rat aortic tissue. Zhao et al. [12] demonstrated that NO up-
regulated the production of H2S via the cGMP pathway.
The mechanism by which NO affects the H2S production
rate was not investigated in this study. It is not clear why
the augmenting effect of SNP only reached significance in
rat fetal membranes.
The endogenous production of H2S under low oxygen 
conditions
The present study is the first to demonstrate the increase
in measured production of H2S under low oxygen condi-
tions in rat and human intrauterine tissues. The produc-
tion rate of H2S was significantly increased (P < 0.05) in
rat liver under low oxygen conditions. Similar results were
observed for rat uterus (Table 3). For rat placenta there
was no significant difference in the production rates of
Table 3: Effect of a low oxygen environment on mean production rates of H2S from homogenates of rat liver, rat intrauterine tissues 
and human placenta (nM/min/g) in the presence and absence (negative control) of 10 mM L-cysteine. 
Tissue Treatment H2S production rate (nM/min/g) Significance
Mean SD n
Rat liver -ve control 4.0 3.5 4
L-cysteine 331 269 4
Low O2 454 205 4 P < 0.05
Rat uterus -ve control 0 0 4
L-cysteine 405 432 4
Low O2 606 620 4 P < 0.05
Rat placenta -ve control 0 0 4
L-cysteine 20 10.9 4
Low O2 17.1 11.2 4 NS
Rat fetal membranes -ve control 0 0 4
L-cysteine 146 120 4
Low O2 490 218 4 P < 0.05
Human placenta -ve control 0 0 4
L-cysteine 200 102 4
Low O2 397 326 4 P < 0.05
A value of 0 indicates below the level of detection.Reproductive Biology and Endocrinology 2009, 7:10 http://www.rbej.com/content/7/1/10
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Expression of CBS and CSE enzymes in rat and human intrauterine tissues Figure 1
Expression of CBS and CSE enzymes in rat and human intrauterine tissues. A Expression of CBS at 15 kDa in rat 
intrauterine tissues. Expression of CBS was detected in pregnant and non-pregnant rat uterus, placenta and fetal membranes. B 
Expression of CSE at 43 kDa in rat intrauterine tissues. Expression of CSE was detected in pregnant and non-pregnant rat 
uterus, placenta and fetal membranes. C Expression of CBS at 48 kDa in human intrauterine tissues. Expression of CBS was 
detected in human chorion, amnion, myometrium and placenta, D Expression of CSE at 43 kDa in human intrauterine tissues. 
Expression of CSE was detected in human chorion, amnion, myometrium and placenta.
A 
 
 
 
B 
 
 
 
C 
 
 
 
D 
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H2S under normal and low oxygen conditions. Rat fetal
membranes followed the same trend as rat liver and rat
uterus under normal and low oxygen conditions. Under
low oxygen conditions the production rate of H2S was sig-
nificantly elevated (P < 0.05). The present study also
investigated the endogenous production of H2S in human
placenta under normal and low oxygen conditions. It is
not clear why a significant increase was seen for human
placenta, but not rat placenta. A significant (P < 0.05)
increase in H2S production was observed in human pla-
centa under low oxygen conditions. Low oxygen condi-
tions were used as hypoxia is associated with pre-
eclampsia, where poor placental function can reduce the
supply of oxygen and nutrients to the fetus resulting in
intrauterine growth restriction (IUGR) and other placen-
tal dysfunctions. Hypoxia can also bring about other pre-
eclamptic features such as the release of proinflammatory
cytokines and oxidative stress [21-23]. Hypoxic condi-
tions can also reduce the uteroplacental perfusion, which
may lead to inflammatory conditions i.e. oxidative stress
[23]. In the present study we found that the endogenous
production of H2S under low oxygen conditions was ele-
vated in rat uterus, fetal membranes and in human pla-
centa in vitro. It is possible that under atmospheric oxygen
conditions some oxidation of evolved H2S could occur,
thus reducing the amount of trapped H2S in the assay.
Under low oxygen conditions perhaps less H2S was oxi-
dised, leading to increased measured production rates of
H2S. However, if it were a simple chemical effect then it
would be expected to affect all H2S production measure-
ments equally, but this was not the case (Table 3). For
example, measured H2S production from rat placenta was
not increased under low oxygen conditions. It seems more
likely that the CBS and CSE enzymes could be directly
affected by oxygen. CBS contains heme in its structure,
which could bind oxygen and affect enzyme function. In
comparison, CSE does not contain heme so an alternative
or novel mechanism could be involved. Clearly there is a
difference between low oxygen incubation for tissue
homogenates in vitro and physiological hypoxia in vivo.
The enzyme function of CBS and CSE appear to be
affected by oxygen levels. It is possible that increased pro-
duction of H2S under hypoxic conditions could have a
role in the pathology of pre-eclampsia.
Expression of cystathionine β-synthase (CBS) and 
cystathionine γ-lyase (CSE)
The human CBS gene has been mapped to chromosome 2
and contains 23 exons. Exons 1–14 and 16 encode the
CBS enzyme. The molecular weight of CBS is 160,000,
and in human and rat liver the primary translational prod-
uct of the CBS gene gives rise to tetrameric subunits of 63
kDa. These subunits are composed of 551 amino acids
residues, and the enzyme also contains the pyridoxal 5'-
phophaste and haem molecule per subunit essential for
its activity [24,25]. The haem molecule could be the direct
target of NO as it can bind to haem with high affinity. The
proteolytic cleavage of the 63 kDa subunit yields a 48 kDa
dimer subunit (40–413 amino acid residue), which is
accompanied by a 60-fold increase in the enzyme's spe-
cific activity with physiological concentrations of homo-
cysteine [24-27].
The presence of CSE has previously been found in rat liver
and in a variety of species including: Neurospora crassa,
Aspergillus nidulans, Saccharomyces cerevisiae and Saccharo-
mycopsis lipoltic [28-30]. CSE has a molecular weight of
166 kDa. Like rat CBS, rat CSE is also composed of 4 iden-
tical tetrameric subunits at 43 kDa and require pyridoxal
5'-phophaste for their activity [28,31]. The cDNA
sequence of rat CSE in comparison to related E. coli
enzymes (cystathionine γ-synthase and cystathionine β-
lyase) share a common ancestral gene as well as identical
tetrameric subunits at 43 kDa. These enzymes from E. coli
are also pyridoxal 5'-phophaste dependent [6]. Expression
of CSE is mainly abundant in vascular tissues, while
expression is increased in fetal liver in later stages of devel-
opment [9,28].
The expression of CSE and CBS has previously been
reported in mammalian tissues. CBS is the main H2S pro-
ducing enzyme in brain tissue [8], while CSE is responsi-
ble for H2S production in vascular tissues [9].
The presence of CBS and CSE has not been previously
reported in rat or human intrauterine tissues. In the
present study, the expression of CBS and CSE was detected
in rat and human intrauterine tissues qualitatively by
Western blotting. CBS was detected at 15 kDa in rat kid-
ney (positive control), non-pregnant uterus, pregnant
uterus, placenta and fetal membranes (Fig. 1a). It is not
clear why a fragment of CBS was detected at 15 kDa in rat
tissue, but at 48 kDa in human tissue. Skovby et al.(1984)
[24] previously reported a 15 kDa peptide cleaved from
CBS by proteolysis. As the primary antibody used was pol-
yclonal it is possible that it bound to an epitope on the 15
kDa fragment from rat CBS. CSE was detected at approxi-
mately 43 kDa in rat aorta (positive control), non-preg-
nant uterus, pregnant uterus, placenta and fetal
membranes (Fig. 1b). These results are in accordance with
Cheng et al. [9] who previously reported the expression of
CSE in rat vascular tissues at 43 kDa.
The present study also detected the presence of CBS and
CSE in human intrauterine tissues. Expression of CBS was
detected in human chorion, amnion, myometrium and
placenta (Fig. 1c). A band at 48 kDa was detected in all tis-
sues, suggesting CBS expression. However, these results
do not agree with the previous findings by Ratnam et al.
[32] who reported expression of CBS at 63 kDa in rat liverReproductive Biology and Endocrinology 2009, 7:10 http://www.rbej.com/content/7/1/10
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cells. It has been previously reported that rat liver CBS has
a subunit at 48 kDa which can be produced by proteolytic
cleavage of the 63 kDa subunit [7,24]. The present study
detected a band at about 48 kDa, which is likely to be the
subunit expression at 48 kDa of CBS. The present study
also investigated the expression of CSE in human chorion,
amnion, myometrium and placenta. The results detected
expression of CSE at 43 kDa in all human tissues (Fig. 1d).
These results agree with similar findings of CSE expression
detected at 43 kDa in rat vascular tissues [9].
This is the first study to report the detection of both CBS
and CSE in rat and human intrauterine tissues and the
production of H2S by these tissues. The results demon-
strated the endogenous production of H2S in rat and
human intrauterine tissues via CBS and CSE enzymes.
Conclusion
Basal production of H2S was demonstrated in rat uterus,
placenta, fetal membranes and human placenta. The
endogenous production of H2S was up-regulated by the
NO donor SNP in rat fetal membranes. Exposure of cell
homogenates from rat liver, uterus, fetal membranes and
human placenta, to low oxygen levels increased H2S pro-
duction rates. The presence of CBS and CSE enzymes was
demonstrated, for the first time, in rat and human intrau-
terine tissues. Endogenously produced H2S could possibly
have a role in the pathology of pre-eclampsia, however
further investigation of the role of H2S in the reproductive
system is required.
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